We aim to be the national and an international leader in genomic medicine to advance research and improve human health

Data Analytics and Interpretation Platform

Data Analytics and Interpretation Platform

Data Analytics and Interpretation Platform

The role of the Data Analytics Platform and its analytical team is to provide current and state-of-the-art data analytics pertaining to all levels of genome analysis in both clinical and research environments.

 

The Analytics Platform provides data analytics services to researchers as well as services for clinical genome interpretation (using both private and public partners) with CE/ISO certification at heart.

 

The Analytics Platform provides a set of quality metrics and quality of assessment for data being generated by the Genome Center and the accompanying analytics pipelines. It performs constant benchmarking against gold standard/FDA-based challenges/TESLA/Synapse and other critical evaluation approaches. The goal is to improve, enhance and describe in detail the caveats and challenges in genomic medicine.

 

The Analytics Platform offers solutions for the data life cycle and proper management of sensitive human genome. In the near future, the platform will provide a phased human genome of clinical utility that can serve as a basis for all types of assessments and analytics by both clinicians and researchers.

The role of the Data Analytics Platform and its analytical team is to provide current and state-of-the-art data analytics pertaining to all levels of genome analysis in both clinical and research environments.

 

The Analytics Platform provides data analytics services to researchers as well as services for clinical genome interpretation (using both private and public partners) with CE/ISO certification at heart.

The Analytics Platform provides a set of quality metrics and quality of assessment for data being generated by the Genome Center and the accompanying analytics pipelines.

 

It performs constant benchmarking against gold standard/FDA-based challenges/TESLA/Synapse and other critical evaluation approaches. The goal is to improve, enhance and describe in detail the caveats and challenges in genomic medicine.

 

The Analytics Platform offers solutions for the data life cycle and proper management of sensitive human genome. In the near future, the platform will provide a phased human genome of clinical utility that can serve as a basis for all types of assessments and analytics by both clinicians and researchers.

The Analytics Platform service offerings in Spring 2019 are:

  • Fast turn-around of WES variants and RNA-Seq quantification,
  • Clinical analytical variant annotation in coordination with external partner hospitals and others,
  • Downstream analytics and interpretation using both public and technology provider solutions.

 

The Analytics Platform service offerings in 2020 onward:

  • Hosting of analysts to co-develop and deploy technology in the remit of the Genome Center for their institutions and groups (area of human genetics and cancer biology),
  • Transformation and implementation of research technology in the Genome Center analytical pipeline (e.g. genome phasing),
  • Training and benchmarking in coordination with academic partners and international bodies (e.g. FDA).

TEAM

TEAM
Ioannis
Xenarios

Chief Data Analyst

Lorenzo Cerutti

Genomics Data Engineer

Cédric Howald

Data Manager, Data Analyst

Arnaud Hungler

Head of IT

Katrin Männik

Head of Data Strategy

Ilya Kolpakov

Genomics Data Engineer

Arkadiy Shevrikuko

Software Engineer

news & events

news & events

Data Analysis and Interpretation at the Health 2030 Genome Center: now and beyond

The first session of the Health 2030 Genome Center Webinar Series was held on April 28, 2021....

Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland

We are centrally contributing to the surveillance of new strains (variants) of SARS-CoV-2 in Switzerland. Read the...

Leena Peltonen School of Human Genomics

The LPSHG Organising Committee has decided to cancel this year´s LPSHG due to the COVID-19 pandemic uncertainty....

To stay informed of our news, register to join our distribution list